|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000116679 |
Summary for IVNS1ABP |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000116679 | Gene symbol | IVNS1ABP |
| Gene name | influenza virus NS1A binding protein | |
| HGNC | 16951 | |
| Entrez ID | 10625 | |
| Gene type | protein_coding | |
| Synonyms | IVNS1ABP|NS1-BP|HSPC068|NS-1|KIAA0850|ND1|KLHL39|ARA3 | |
| UniProtAcc | Q9Y6Y0 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for IVNS1ABP |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| IVNS1ABP | 1.09e+04 | -1.15e+00 | 1.46e-01 | -7.85e+00 | 4.05e-15 | 4.80e-14 | KIRP |
| IVNS1ABP | 7.20e+03 | 1.42e+00 | 4.30e-01 | 3.30e+00 | 9.81e-04 | 3.34e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for IVNS1ABP |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for IVNS1ABP |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LIHC | cg17297305 | chr1:185318016 | CGI:chr1:185316197-185317234 | promoter | 5.24e-01 | 4.23e-01 | 2.77e+00 | 5.59e-03 | 7.29e-03 | 1.01e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for IVNS1ABP |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for IVNS1ABP |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for IVNS1ABP |
| TFs related to IVNS1ABP. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | ALX1 | IVNS1ABP | 3.28e+00 | 2.77e-03 | 4.53e+00 | 9.91e-01 | Female-biased |
| DLBC | ALX3 | IVNS1ABP | 3.91e+00 | 4.62e-03 | 5.03e+00 | 9.93e-01 | Female-biased |
| DLBC | ALX4 | IVNS1ABP | 3.81e+00 | 4.42e-03 | 4.94e+00 | 9.92e-01 | Female-biased |
| DLBC | ARGFX | IVNS1ABP | 3.71e+00 | 3.22e-03 | 4.93e+00 | 9.93e-01 | Female-biased |
| DLBC | DRGX | IVNS1ABP | 3.67e+00 | 4.22e-03 | 4.81e+00 | 9.92e-01 | Female-biased |
| DLBC | FOXC1 | IVNS1ABP | 2.90e+00 | 2.87e-03 | 4.13e+00 | 9.85e-01 | Female-biased |
| DLBC | FOXD3 | IVNS1ABP | 2.52e+00 | 1.09e-03 | 4.03e+00 | 9.85e-01 | Female-biased |
| DLBC | FOXF1 | IVNS1ABP | 2.81e+00 | 2.04e-03 | 4.14e+00 | 9.86e-01 | Female-biased |
| DLBC | FOXG1 | IVNS1ABP | 2.30e+00 | 8.81e-04 | 3.87e+00 | 9.81e-01 | Female-biased |
| DLBC | HMX1 | IVNS1ABP | 3.33e+00 | 4.92e-03 | 4.42e+00 | 9.88e-01 | Female-biased |
| DLBC | IRF1 | IVNS1ABP | 2.57e+00 | 1.24e-03 | 4.04e+00 | 9.85e-01 | Female-biased |
| DLBC | IRX1 | IVNS1ABP | 3.68e+00 | 1.19e-02 | 4.53e+00 | 9.82e-01 | Female-biased |
| DLBC | ISX | IVNS1ABP | 3.48e+00 | 3.42e-03 | 4.67e+00 | 9.92e-01 | Female-biased |
| DLBC | MEF2A | IVNS1ABP | 2.62e+00 | 2.04e-03 | 3.94e+00 | 9.82e-01 | Female-biased |
| DLBC | MESP2 | IVNS1ABP | 4.25e+00 | 1.61e-02 | 5.02e+00 | 9.81e-01 | Female-biased |
| DLBC | MYNN | IVNS1ABP | 2.75e+00 | 1.94e-03 | 4.09e+00 | 9.85e-01 | Female-biased |
| DLBC | NKX3-2 | IVNS1ABP | 3.32e+00 | 4.10e-03 | 4.46e+00 | 9.89e-01 | Female-biased |
| DLBC | NKX6-1 | IVNS1ABP | 2.47e+00 | 1.31e-03 | 3.92e+00 | 9.82e-01 | Female-biased |
| DLBC | NR4A2 | IVNS1ABP | 3.47e+00 | 1.04e-02 | 4.36e+00 | 9.81e-01 | Female-biased |
| DLBC | PHOX2A | IVNS1ABP | 3.65e+00 | 3.56e-03 | 4.83e+00 | 9.93e-01 | Female-biased |
| DLBC | PHOX2B | IVNS1ABP | 3.25e+00 | 2.49e-03 | 4.53e+00 | 9.91e-01 | Female-biased |
| DLBC | POU2F2 | IVNS1ABP | 3.04e+00 | 3.56e-03 | 4.22e+00 | 9.86e-01 | Female-biased |
| DLBC | POU5F1 | IVNS1ABP | 3.02e+00 | 3.17e-03 | 4.22e+00 | 9.86e-01 | Female-biased |
| DLBC | PROP1 | IVNS1ABP | 3.89e+00 | 5.26e-03 | 4.96e+00 | 9.92e-01 | Female-biased |
| DLBC | PRRX1 | IVNS1ABP | 3.53e+00 | 3.12e-03 | 4.75e+00 | 9.92e-01 | Female-biased |
| DLBC | SOX2 | IVNS1ABP | 3.09e+00 | 2.70e-03 | 4.34e+00 | 9.89e-01 | Female-biased |
| DLBC | SOX7 | IVNS1ABP | 2.98e+00 | 2.06e-03 | 4.30e+00 | 9.89e-01 | Female-biased |
| DLBC | SRY | IVNS1ABP | 3.30e+00 | 2.25e-03 | 4.61e+00 | 9.92e-01 | Female-biased |
| DLBC | UNCX | IVNS1ABP | 3.52e+00 | 4.10e-03 | 4.66e+00 | 9.91e-01 | Female-biased |
| DLBC | ZFP82 | IVNS1ABP | 2.55e+00 | 1.32e-03 | 4.00e+00 | 9.84e-01 | Female-biased |
| DLBC | ZNF136 | IVNS1ABP | 2.94e+00 | 4.27e-03 | 4.06e+00 | 9.82e-01 | Female-biased |
| DLBC | ZNF211 | IVNS1ABP | 4.57e+00 | 1.35e-02 | 5.39e+00 | 9.85e-01 | Female-biased |
| DLBC | ZNF25 | IVNS1ABP | 2.38e+00 | 8.10e-04 | 3.98e+00 | 9.84e-01 | Female-biased |
| DLBC | ZNF334 | IVNS1ABP | 2.28e+00 | 3.76e-04 | 4.13e+00 | 9.88e-01 | Female-biased |
| DLBC | ZNF33B | IVNS1ABP | 2.60e+00 | 1.04e-03 | 4.12e+00 | 9.87e-01 | Female-biased |
| DLBC | ZNF354A | IVNS1ABP | 3.13e+00 | 3.62e-03 | 4.30e+00 | 9.87e-01 | Female-biased |
| DLBC | ZNF410 | IVNS1ABP | 3.59e+00 | 1.24e-02 | 4.43e+00 | 9.80e-01 | Female-biased |
| DLBC | ZNF418 | IVNS1ABP | 2.25e+00 | 3.45e-04 | 4.12e+00 | 9.88e-01 | Female-biased |
| DLBC | ZNF580 | IVNS1ABP | 3.15e+00 | 1.60e-03 | 4.56e+00 | 9.92e-01 | Female-biased |
| MESO | ALX1 | IVNS1ABP | 3.59e+00 | 8.80e-03 | 4.91e+00 | 9.87e-01 | Female-biased |
| MESO | ALX4 | IVNS1ABP | 4.13e+00 | 1.71e-02 | 5.24e+00 | 9.80e-01 | Female-biased |
| MESO | DRGX | IVNS1ABP | 3.89e+00 | 1.43e-02 | 5.06e+00 | 9.83e-01 | Female-biased |
| MESO | ELF3 | IVNS1ABP | 2.62e+00 | 3.99e-03 | 4.16e+00 | 9.84e-01 | Female-biased |
| MESO | FOXD3 | IVNS1ABP | 2.66e+00 | 1.47e-03 | 4.48e+00 | 9.91e-01 | Female-biased |
| MESO | FOXF1 | IVNS1ABP | 2.92e+00 | 4.67e-03 | 4.42e+00 | 9.87e-01 | Female-biased |
| MESO | FOXG1 | IVNS1ABP | 2.31e+00 | 1.05e-03 | 4.21e+00 | 9.88e-01 | Female-biased |
| MESO | FOXJ2 | IVNS1ABP | 2.21e+00 | 1.86e-03 | 3.96e+00 | 9.83e-01 | Female-biased |
| MESO | FOXJ3 | IVNS1ABP | 2.46e+00 | 2.70e-03 | 4.11e+00 | 9.85e-01 | Female-biased |
| MESO | HMX1 | IVNS1ABP | 3.58e+00 | 1.12e-02 | 4.82e+00 | 9.84e-01 | Female-biased |
| MESO | IRF1 | IVNS1ABP | 2.78e+00 | 4.93e-03 | 4.26e+00 | 9.85e-01 | Female-biased |
| MESO | ISX | IVNS1ABP | 3.76e+00 | 1.09e-02 | 5.01e+00 | 9.86e-01 | Female-biased |
| MESO | MEF2A | IVNS1ABP | 2.55e+00 | 2.87e-03 | 4.19e+00 | 9.86e-01 | Female-biased |
| MESO | MYNN | IVNS1ABP | 2.83e+00 | 3.97e-03 | 4.38e+00 | 9.87e-01 | Female-biased |
| MESO | NKX3-2 | IVNS1ABP | 3.48e+00 | 6.63e-03 | 4.89e+00 | 9.89e-01 | Female-biased |
| MESO | NKX6-1 | IVNS1ABP | 2.46e+00 | 8.67e-04 | 4.41e+00 | 9.91e-01 | Female-biased |
| MESO | PHOX2A | IVNS1ABP | 3.95e+00 | 1.54e-02 | 5.09e+00 | 9.82e-01 | Female-biased |
| MESO | PHOX2B | IVNS1ABP | 3.54e+00 | 9.69e-03 | 4.82e+00 | 9.86e-01 | Female-biased |
| MESO | POU2F2 | IVNS1ABP | 3.18e+00 | 9.04e-03 | 4.48e+00 | 9.83e-01 | Female-biased |
| MESO | POU5F1 | IVNS1ABP | 3.11e+00 | 1.07e-02 | 4.35e+00 | 9.80e-01 | Female-biased |
| MESO | PROP1 | IVNS1ABP | 4.18e+00 | 1.71e-02 | 5.29e+00 | 9.81e-01 | Female-biased |
| MESO | PRRX1 | IVNS1ABP | 3.86e+00 | 1.36e-02 | 5.04e+00 | 9.83e-01 | Female-biased |
| MESO | SOX2 | IVNS1ABP | 3.30e+00 | 9.49e-03 | 4.59e+00 | 9.84e-01 | Female-biased |
| MESO | SOX7 | IVNS1ABP | 3.19e+00 | 7.35e-03 | 4.56e+00 | 9.86e-01 | Female-biased |
| MESO | SRY | IVNS1ABP | 3.56e+00 | 9.76e-03 | 4.84e+00 | 9.86e-01 | Female-biased |
| MESO | UNCX | IVNS1ABP | 3.79e+00 | 1.39e-02 | 4.97e+00 | 9.83e-01 | Female-biased |
| MESO | ZFP82 | IVNS1ABP | 2.67e+00 | 4.75e-03 | 4.15e+00 | 9.83e-01 | Female-biased |
| MESO | ZNF136 | IVNS1ABP | 3.03e+00 | 7.03e-03 | 4.41e+00 | 9.85e-01 | Female-biased |
| MESO | ZNF175 | IVNS1ABP | 2.69e+00 | 4.62e-03 | 4.19e+00 | 9.84e-01 | Female-biased |
| MESO | ZNF25 | IVNS1ABP | 2.30e+00 | 6.56e-04 | 4.32e+00 | 9.90e-01 | Female-biased |
| MESO | ZNF334 | IVNS1ABP | 2.30e+00 | 1.92e-04 | 4.61e+00 | 9.94e-01 | Female-biased |
| MESO | ZNF33B | IVNS1ABP | 2.90e+00 | 3.77e-03 | 4.47e+00 | 9.89e-01 | Female-biased |
| MESO | ZNF354A | IVNS1ABP | 3.21e+00 | 8.56e-03 | 4.53e+00 | 9.84e-01 | Female-biased |
| MESO | ZNF418 | IVNS1ABP | 1.58e+00 | 2.99e-05 | 4.37e+00 | 9.92e-01 | Female-biased |
| MESO | ZNF570 | IVNS1ABP | 1.90e+00 | 6.77e-04 | 3.91e+00 | 9.83e-01 | Female-biased |
| MESO | ZNF580 | IVNS1ABP | 3.20e+00 | 4.74e-03 | 4.70e+00 | 9.90e-01 | Female-biased |
| MESO | ZNF879 | IVNS1ABP | 1.71e+00 | 3.05e-04 | 3.91e+00 | 9.83e-01 | Female-biased |
| PAAD | ALX1 | IVNS1ABP | 4.57e+00 | 9.92e-01 | 3.45e+00 | 2.29e-03 | Male-biased |
| PAAD | ALX3 | IVNS1ABP | 5.12e+00 | 9.92e-01 | 4.16e+00 | 5.27e-03 | Male-biased |
| PAAD | ALX4 | IVNS1ABP | 5.06e+00 | 9.91e-01 | 4.13e+00 | 6.21e-03 | Male-biased |
| PAAD | ARGFX | IVNS1ABP | 5.06e+00 | 9.95e-01 | 3.94e+00 | 2.42e-03 | Male-biased |
| PAAD | DRGX | IVNS1ABP | 4.91e+00 | 9.93e-01 | 3.85e+00 | 3.20e-03 | Male-biased |
| PAAD | DUXA | IVNS1ABP | 4.58e+00 | 9.87e-01 | 3.69e+00 | 7.46e-03 | Male-biased |
| PAAD | ELF3 | IVNS1ABP | 3.92e+00 | 9.83e-01 | 2.59e+00 | 7.14e-04 | Male-biased |
| PAAD | FOXC1 | IVNS1ABP | 4.25e+00 | 9.88e-01 | 3.07e+00 | 1.60e-03 | Male-biased |
| PAAD | FOXD3 | IVNS1ABP | 4.17e+00 | 9.88e-01 | 2.62e+00 | 2.22e-04 | Male-biased |
| PAAD | FOXF1 | IVNS1ABP | 4.17e+00 | 9.88e-01 | 2.89e+00 | 1.01e-03 | Male-biased |
| PAAD | FOXG1 | IVNS1ABP | 3.97e+00 | 9.85e-01 | 2.49e+00 | 3.12e-04 | Male-biased |
| PAAD | FOXJ3 | IVNS1ABP | 3.88e+00 | 9.82e-01 | 2.57e+00 | 8.07e-04 | Male-biased |
| PAAD | GATA1 | IVNS1ABP | 5.82e+00 | 9.86e-01 | 5.03e+00 | 1.30e-02 | Male-biased |
| PAAD | HMX1 | IVNS1ABP | 4.58e+00 | 9.91e-01 | 3.50e+00 | 2.81e-03 | Male-biased |
| PAAD | IRF1 | IVNS1ABP | 4.04e+00 | 9.85e-01 | 2.87e+00 | 1.64e-03 | Male-biased |
| PAAD | IRX1 | IVNS1ABP | 4.58e+00 | 9.81e-01 | 3.80e+00 | 1.31e-02 | Male-biased |
| PAAD | ISX | IVNS1ABP | 4.74e+00 | 9.94e-01 | 3.57e+00 | 1.84e-03 | Male-biased |
| PAAD | MEF2A | IVNS1ABP | 3.98e+00 | 9.84e-01 | 2.69e+00 | 8.88e-04 | Male-biased |
| PAAD | MYNN | IVNS1ABP | 4.13e+00 | 9.87e-01 | 2.86e+00 | 1.04e-03 | Male-biased |
| PAAD | NKX3-2 | IVNS1ABP | 4.50e+00 | 9.91e-01 | 3.34e+00 | 1.87e-03 | Male-biased |
| PAAD | NKX6-1 | IVNS1ABP | 4.09e+00 | 9.87e-01 | 2.54e+00 | 2.15e-04 | Male-biased |
| PAAD | PHOX2A | IVNS1ABP | 4.92e+00 | 9.93e-01 | 3.88e+00 | 3.45e-03 | Male-biased |
| PAAD | PHOX2B | IVNS1ABP | 4.55e+00 | 9.92e-01 | 3.42e+00 | 2.19e-03 | Male-biased |
| PAAD | POU2F2 | IVNS1ABP | 4.38e+00 | 9.90e-01 | 3.26e+00 | 2.24e-03 | Male-biased |
| PAAD | POU5F1 | IVNS1ABP | 4.26e+00 | 9.88e-01 | 3.14e+00 | 2.22e-03 | Male-biased |
| PAAD | PRDM1 | IVNS1ABP | 4.00e+00 | 9.83e-01 | 2.87e+00 | 2.08e-03 | Male-biased |
| PAAD | PROP1 | IVNS1ABP | 5.09e+00 | 9.94e-01 | 4.07e+00 | 3.82e-03 | Male-biased |
| PAAD | PRRX1 | IVNS1ABP | 4.81e+00 | 9.92e-01 | 3.77e+00 | 3.46e-03 | Male-biased |
| PAAD | SOX2 | IVNS1ABP | 4.41e+00 | 9.89e-01 | 3.32e+00 | 2.67e-03 | Male-biased |
| PAAD | SOX7 | IVNS1ABP | 4.29e+00 | 9.89e-01 | 3.14e+00 | 1.95e-03 | Male-biased |
| PAAD | SRY | IVNS1ABP | 4.62e+00 | 9.92e-01 | 3.53e+00 | 2.80e-03 | Male-biased |
| PAAD | UNCX | IVNS1ABP | 4.78e+00 | 9.93e-01 | 3.65e+00 | 2.26e-03 | Male-biased |
| PAAD | ZFP82 | IVNS1ABP | 3.98e+00 | 9.84e-01 | 2.62e+00 | 6.43e-04 | Male-biased |
| PAAD | ZNF136 | IVNS1ABP | 4.17e+00 | 9.86e-01 | 3.04e+00 | 2.11e-03 | Male-biased |
| PAAD | ZNF175 | IVNS1ABP | 3.93e+00 | 9.83e-01 | 2.61e+00 | 7.40e-04 | Male-biased |
| PAAD | ZNF211 | IVNS1ABP | 5.53e+00 | 9.89e-01 | 4.69e+00 | 9.55e-03 | Male-biased |
| PAAD | ZNF25 | IVNS1ABP | 3.96e+00 | 9.84e-01 | 2.38e+00 | 1.81e-04 | Male-biased |
| PAAD | ZNF334 | IVNS1ABP | 4.24e+00 | 9.90e-01 | 2.43e+00 | 4.89e-05 | Male-biased |
| PAAD | ZNF33B | IVNS1ABP | 4.16e+00 | 9.88e-01 | 2.82e+00 | 6.98e-04 | Male-biased |
| PAAD | ZNF354A | IVNS1ABP | 4.40e+00 | 9.90e-01 | 3.26e+00 | 2.10e-03 | Male-biased |
| PAAD | ZNF410 | IVNS1ABP | 4.55e+00 | 9.81e-01 | 3.77e+00 | 1.31e-02 | Male-biased |
| PAAD | ZNF418 | IVNS1ABP | 4.01e+00 | 9.86e-01 | 2.19e+00 | 4.60e-05 | Male-biased |
| PAAD | ZNF580 | IVNS1ABP | 4.51e+00 | 9.93e-01 | 3.16e+00 | 6.87e-04 | Male-biased |
| PAAD | ZSCAN9 | IVNS1ABP | 4.07e+00 | 9.82e-01 | 3.09e+00 | 4.72e-03 | Male-biased |
| IVNS1ABP related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for IVNS1ABP |
| RBPs related to ES in IVNS1ABP. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | RBMS1 | exon_skip_35080 | 1.35e+01 | 9.79e-04 | 1.41e+01 | 9.99e-01 | Female-biased |
| STAD | SAMD4A | exon_skip_35062 | 6.58e+00 | 9.83e-01 | 5.59e+00 | 1.20e-04 | Male-biased |
| STAD | SART3 | exon_skip_35074 | 9.07e+00 | 9.81e-01 | 8.76e+00 | 1.50e-02 | Male-biased |
| UVM | BRUNOL6 | exon_skip_35087 | 8.44e+00 | 5.10e-03 | 8.79e+00 | 9.90e-01 | Female-biased |
| THYM | BRUNOL6 | exon_skip_35087 | 8.84e+00 | 9.92e-01 | 8.39e+00 | 2.52e-03 | Male-biased |
| THYM | RBMS1 | exon_skip_35080 | 1.41e+01 | 2.65e-04 | 1.48e+01 | 1.00e+00 | Female-biased |
| DLBC | BRUNOL6 | exon_skip_35087 | 8.88e+00 | 9.91e-01 | 8.46e+00 | 3.83e-03 | Male-biased |
| DLBC | RBMS1 | exon_skip_35080 | 1.40e+01 | 1.14e-02 | 1.44e+01 | 9.88e-01 | Female-biased |
| CHOL | BRUNOL6 | exon_skip_35087 | 8.82e+00 | 9.90e-01 | 8.33e+00 | 4.76e-03 | Male-biased |
| KIRP | SART3 | exon_skip_35074 | 9.12e+00 | 9.88e-01 | 8.76e+00 | 7.82e-03 | Male-biased |
| BRCA | RBMS1 | exon_skip_35080 | 1.42e+01 | 9.82e-01 | 1.37e+01 | 1.81e-02 | Male-biased |
| READ | RBMS1 | exon_skip_35080 | 1.37e+01 | 7.07e-04 | 1.43e+01 | 9.99e-01 | Female-biased |
| MESO | BRUNOL6 | exon_skip_35087 | 8.46e+00 | 7.60e-03 | 8.83e+00 | 9.87e-01 | Female-biased |
| MESO | RBMS1 | exon_skip_35080 | 1.41e+01 | 6.49e-04 | 1.47e+01 | 9.99e-01 | Female-biased |
| GBM | RBMS1 | exon_skip_35080 | 1.43e+01 | 9.99e-01 | 1.38e+01 | 1.23e-03 | Male-biased |
| KIRC | BRUNOL6 | exon_skip_35087 | 8.44e+00 | 7.40e-03 | 8.79e+00 | 9.88e-01 | Female-biased |
| SARC | RBMS1 | exon_skip_35080 | 1.47e+01 | 9.98e-01 | 1.41e+01 | 1.83e-03 | Male-biased |
| IVNS1ABP related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000116679 | AL390294.1,hsa-mir-203a,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | AC006946.2,hsa-mir-203a,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | LINC01649,hsa-mir-31,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | AC016705.2,hsa-mir-31,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | LINC01116,hsa-mir-31,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | AC005082.1,hsa-mir-31,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | AC006116.6,hsa-mir-497,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | TEX41,hsa-mir-497,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | TEX41,hsa-mir-500b,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
| ENSG00000116679 | MAP4K3-DT,hsa-mir-500b,IVNS1ABP | Male-specific ceRNA | TCGA-KIRP |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs16857712 | chr1:181577382:G:C | - | 0.288004123883806 | 0.0028138547954477 | GBM | Female-baised eQTL |
| rs77757639 | chr1:181578162:A:G | - | 0.288004123883806 | 0.0028138547954477 | GBM | Female-baised eQTL |
| rs76889591 | chr1:181583198:T:G | - | 0.288004123883806 | 0.0028138547954477 | GBM | Female-baised eQTL |
| rs12239392 | chr1:181583934:G:A | - | 0.288004123883806 | 0.0028138547954477 | GBM | Female-baised eQTL |
| rs4360493 | chr1:181584263:T:G | - | 0.288004123883806 | 0.0028138547954477 | GBM | Female-baised eQTL |
| rs60256303 | chr1:181656131:C:T | - | 0.342187518572766 | 0.00660482965063749 | GBM | Female-baised eQTL |
| rs10798744 | chr1:180312210:G:A | - | -0.320503776826023 | 0.00939921744707912 | GBM | Female-baised eQTL |
| rs2794972 | chr1:180307000:A:C | - | 0.320503776826023 | 0.00939921744707912 | GBM | Female-baised eQTL |
| rs2764453 | chr1:180280172:T:C | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2794965 | chr1:180280637:C:T | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2764456 | chr1:180284426:C:T | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2764458 | chr1:180284834:C:G | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2794966 | chr1:180285526:T:C | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2794967 | chr1:180285647:G:C | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2794968 | chr1:180285730:T:C | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2764459 | chr1:180286063:A:T | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2764461 | chr1:180287554:G:T | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2764468 | chr1:180300635:T:G | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs9425490 | chr1:180302780:A:G | - | 0.319051367831846 | 0.0105443429051528 | GBM | Female-baised eQTL |
| rs2794974 | chr1:180313650:G:C | - | 0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs2764436 | chr1:180316782:A:G | - | 0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs2764438 | chr1:180318284:C:T | - | 0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs2764444 | chr1:180324727:A:G | - | 0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs863721 | chr1:180329336:C:T | - | 0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs1961741 | chr1:180321693:T:G | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs151231956 | chr1:180337028:A:G | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs6664944 | chr1:180339718:A:G | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs4651062 | chr1:180356061:C:T | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs6425623 | chr1:180356878:T:C | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs6659147 | chr1:180356994:A:C | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs1418101 | chr1:180363686:A:G | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs4333819 | chr1:180366129:T:C | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs4281291 | chr1:180368108:G:C | - | -0.280863806626361 | 0.0284389046509343 | GBM | Female-baised eQTL |
| rs2262371 | chr1:180319966:C:G | - | 0.279411397632184 | 0.0315521177858391 | GBM | Female-baised eQTL |
| rs72734937 | chr1:192559115:T:C | - | 0.19071469925819 | 0.0312466924952678 | KIRP | Female-baised eQTL |
| rs12097386 | chr1:192559521:C:T | - | 0.19071469925819 | 0.0312466924952678 | KIRP | Female-baised eQTL |
| rs75292482 | chr1:192563903:A:G | - | 0.190440060772688 | 0.0315763235368219 | KIRP | Female-baised eQTL |
| rs10921195 | chr1:192564116:G:A | - | 0.190440060772688 | 0.0315763235368219 | KIRP | Female-baised eQTL |
| rs10921196 | chr1:192564388:C:T | - | 0.190440060772688 | 0.0315763235368219 | KIRP | Female-baised eQTL |
| rs12134954 | chr1:179670944:A:G | - | 0.201703132619311 | 0.042168114642199 | KIRP | Female-baised eQTL |
| rs6678778 | chr1:181211424:A:G | - | -0.0771204025075884 | 0.0225051317649432 | LUAD | Female-baised eQTL |
| rs3908964 | chr1:191864689:G:A | - | 0.0550205250712995 | 0.0324881223089376 | LUAD | Female-baised eQTL |
| rs2446388 | chr1:181270144:A:G | - | -0.0472984071285962 | 0.0371645627845911 | LUAD | Female-baised eQTL |
| rs6680867 | chr1:181275612:A:G | - | -0.0472984071285962 | 0.0371645627845911 | LUAD | Female-baised eQTL |
| rs950568 | chr1:189871924:T:G | - | 0.0432383539281692 | 0.0444433394203359 | LUAD | Female-baised eQTL |
| rs1544173 | chr1:181209875:G:C | - | -0.0714819988773733 | 0.0446078661957166 | LUAD | Female-baised eQTL |
| rs1380081 | chr1:181262886:T:C | - | -0.0473386111949195 | 0.0449920891841116 | LUAD | Female-baised eQTL |
| rs11803277 | chr1:187640898:T:G | - | 0.0452869746489574 | 0.0450776858330896 | LUAD | Female-baised eQTL |
| rs61822202 | chr1:187641645:C:G | - | 0.0450478883111213 | 0.0461341636585425 | LUAD | Female-baised eQTL |
| rs4652626 | chr1:181247943:T:C | - | -0.046796937828666 | 0.0483387860534213 | LUAD | Female-baised eQTL |
| rs58569084 | chr1:181248719:A:T | - | -0.046796937828666 | 0.0483387860534213 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7542913 | chr1:184705692:C:T | - | 0.386401839175326 | 0.00867429212032032 | PCPG | Male-baised eQTL |
| rs66640078 | chr1:184722200:T:C | - | 0.386401839175326 | 0.00867429212032032 | PCPG | Male-baised eQTL |
| rs800799 | chr1:187894762:C:T | - | -0.061591354063478 | 0.0078380843581752 | BLCA | Male-baised eQTL |
| rs12075231 | chr1:188586757:T:A | - | -0.0879122490631123 | 0.0121641793427356 | BLCA | Male-baised eQTL |
| rs10912450 | chr1:188564169:G:A | - | -0.0787540392201128 | 0.0122508772904622 | BLCA | Male-baised eQTL |
| rs1482500 | chr1:188574835:C:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs6701643 | chr1:188575553:G:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1973231 | chr1:188575759:C:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1552171 | chr1:188575955:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs11588330 | chr1:188576087:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28478563 | chr1:188576215:C:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28615992 | chr1:188576263:A:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28453096 | chr1:188576306:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28667672 | chr1:188576573:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28374083 | chr1:188576931:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28693909 | chr1:188576945:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28728397 | chr1:188577127:T:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28451395 | chr1:188577387:G:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1600915 | chr1:188577544:A:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1600916 | chr1:188577562:C:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28641180 | chr1:188577876:T:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28494554 | chr1:188578014:A:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28738695 | chr1:188578133:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28541805 | chr1:188578452:A:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28399678 | chr1:188578466:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs12036897 | chr1:188578973:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs10912453 | chr1:188580193:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs10912454 | chr1:188580239:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs12041145 | chr1:188580266:A:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs12037953 | chr1:188580277:T:G | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1902901 | chr1:188580816:G:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1384354 | chr1:188580892:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs967355 | chr1:188581783:T:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs967356 | chr1:188581848:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs967358 | chr1:188582278:T:C | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1609769 | chr1:188583690:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1609770 | chr1:188583835:C:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1609771 | chr1:188584386:C:T | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs1609773 | chr1:188584694:C:A | - | -0.0876798281493386 | 0.0126252556899625 | BLCA | Male-baised eQTL |
| rs28544369 | chr1:188585748:T:G | - | -0.0875441799179611 | 0.0129080295059355 | BLCA | Male-baised eQTL |
| rs16829099 | chr1:188585875:G:A | - | -0.0875441799179611 | 0.0129080295059355 | BLCA | Male-baised eQTL |
| rs16829103 | chr1:188585919:T:C | - | -0.0875441799179611 | 0.0129080295059355 | BLCA | Male-baised eQTL |
| rs16829106 | chr1:188585970:T:C | - | -0.0875441799179611 | 0.0129080295059355 | BLCA | Male-baised eQTL |
| rs28809835 | chr1:188548381:T:C | - | -0.0874558701877446 | 0.0130219393487825 | BLCA | Male-baised eQTL |
| rs10912433 | chr1:188550337:G:A | - | -0.0874558701877446 | 0.0130219393487825 | BLCA | Male-baised eQTL |
| rs28680731 | chr1:188550131:C:T | - | -0.0868755747605347 | 0.0142189721791184 | BLCA | Male-baised eQTL |
| rs6697369 | chr1:188550835:C:T | - | -0.0868755747605347 | 0.0142189721791184 | BLCA | Male-baised eQTL |
| rs75525523 | chr1:184127705:A:G | - | 0.0900973924356292 | 0.0153640369473007 | BLCA | Male-baised eQTL |
| rs7528006 | chr1:184123433:A:G | - | 0.093201205528578 | 0.0158765634555289 | BLCA | Male-baised eQTL |
| rs11803632 | chr1:184136543:T:A | - | 0.093201205528578 | 0.0158765634555289 | BLCA | Male-baised eQTL |
| rs10912210 | chr1:187914661:G:A | - | 0.0569664820676334 | 0.0206163391655201 | BLCA | Male-baised eQTL |
| rs1572507 | chr1:187915241:G:A | - | 0.0569664820676334 | 0.0206163391655201 | BLCA | Male-baised eQTL |
| rs6662623 | chr1:188551245:A:G | - | -0.0826127232420336 | 0.022064329596759 | BLCA | Male-baised eQTL |
| rs10912435 | chr1:188551498:C:G | - | -0.0826127232420336 | 0.022064329596759 | BLCA | Male-baised eQTL |
| rs56964008 | chr1:187906137:G:C | - | 0.0562569630644856 | 0.0238417710396475 | BLCA | Male-baised eQTL |
| rs147167108 | chr1:184109002:T:C | - | 0.0887348614750873 | 0.0288004804887461 | BLCA | Male-baised eQTL |
| rs114231218 | chr1:184110961:T:C | - | 0.0887348614750873 | 0.0288004804887461 | BLCA | Male-baised eQTL |
| rs28568689 | chr1:188578467:A:G | - | -0.077989433547945 | 0.0309620709401911 | BLCA | Male-baised eQTL |
| rs10753948 | chr1:190572929:T:C | - | -0.0333615960545648 | 0.0487930512081156 | BLCA | Male-baised eQTL |
| rs1929219 | chr1:194760813:G:A | - | 0.0898471080894916 | 0.000371895570757499 | COAD | Male-baised eQTL |
| rs12143741 | chr1:177792679:T:G | - | 0.108438814865339 | 0.00127935022822933 | COAD | Male-baised eQTL |
| rs6691362 | chr1:194603155:C:T | - | 0.0777460257912043 | 0.00346796501172691 | COAD | Male-baised eQTL |
| rs12035833 | chr1:194600642:G:C | - | 0.0749758877324353 | 0.00896297511268631 | COAD | Male-baised eQTL |
| rs59926413 | chr1:194722512:A:C | - | 0.11801805763711 | 0.0379604323195422 | COAD | Male-baised eQTL |
| rs10921078 | chr1:192089892:G:A | - | 0.0713055865177672 | 0.0396596691124321 | COAD | Male-baised eQTL |
| rs17622650 | chr1:194434443:G:T | - | 0.108829620738258 | 0.0409362488330112 | COAD | Male-baised eQTL |
| rs588492 | chr1:183285932:G:A | - | -0.0472058885067563 | 0.0419635679209699 | COAD | Male-baised eQTL |
| rs1498123 | chr1:179712844:T:G | - | 0.053746954439452 | 0.0437496245588661 | COAD | Male-baised eQTL |
| rs17392985 | chr1:191330381:T:A | - | 0.0987167193774685 | 0.0445638642092367 | COAD | Male-baised eQTL |
| rs6683309 | chr1:179387446:C:T | - | -0.0494337120396857 | 0.0454443177396791 | COAD | Male-baised eQTL |
| rs6656281 | chr1:175917375:A:G | - | 0.0473533314645165 | 0.0488598036729068 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of IVNS1ABP |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000116679 | IVNS1ABP | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000116679 | IVNS1ABP | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
